208 related articles for article (PubMed ID: 30951617)
1. Does metabolic control affect salivary adipokines in type 2 diabetes mellitus?
Teke E; Kırzıoğlu FY; Korkmaz H; Calapoğlu M; Orhan H
Dent Med Probl; 2019; 56(1):11-20. PubMed ID: 30951617
[TBL] [Abstract][Full Text] [Related]
2. Salivary interleukin-17 and tumor necrosis factor-α in relation to periodontitis and glycemic status in type 2 diabetes mellitus.
Gürsoy UK; Yildiz Çiftlikli S; Könönen E; Gürsoy M; Doğan B
J Diabetes; 2015 Sep; 7(5):681-8. PubMed ID: 25327309
[TBL] [Abstract][Full Text] [Related]
3. Levels of vaspin and omentin-1 in gingival crevicular fluid as potential markers of inflammation in patients with chronic periodontitis and type 2 diabetes mellitus.
Bozkurt Doğan Ş; Öngöz Dede F; Ballı U; Sertoğlu E
J Oral Sci; 2016; 58(3):379-89. PubMed ID: 27665978
[TBL] [Abstract][Full Text] [Related]
4. Serum and salivary adipokines in type 2 diabetes - Results of a pilot study in India.
Vinitha R; Yogalakshmi R; Rajeswari A; Snehalatha C; Nair DR; Susairaj P; Satheesh K; Nanditha A; Raghavan A; Arun KV; Ramachandran A
Diabetes Metab Syndr; 2022 Jul; 16(7):102536. PubMed ID: 35717896
[TBL] [Abstract][Full Text] [Related]
5. Correlation of periodontal inflamed surface area with glycated hemoglobin, interleukin-6 and lipoprotein(a) in type 2 diabetes with retinopathy.
Thazhe Poyil NJ; Vadakkekuttical RJ; Radhakrishnan C
World J Diabetes; 2024 Apr; 15(4):686-696. PubMed ID: 38680698
[TBL] [Abstract][Full Text] [Related]
6. Salivary antioxidants in patients with type 1 or 2 diabetes and inflammatory periodontal disease: a case-control study.
Gümüş P; Buduneli N; Cetinkalp S; Hawkins SI; Renaud D; Kinane DF; Scott DA
J Periodontol; 2009 Sep; 80(9):1440-6. PubMed ID: 19722794
[TBL] [Abstract][Full Text] [Related]
7. Correlation of periodontal inflamed surface area with glycemic status in controlled and uncontrolled type 2 diabetes mellitus.
Anil K; Vadakkekuttical RJ; Radhakrishnan C; Parambath FC
World J Clin Cases; 2021 Dec; 9(36):11300-11310. PubMed ID: 35071560
[TBL] [Abstract][Full Text] [Related]
8. Is obesity associated with healing after non-surgical periodontal therapy? A local vs. systemic evaluation.
Duzagac E; Cifcibasi E; Erdem MG; Karabey V; Kasali K; Badur S; Cintan S
J Periodontal Res; 2016 Oct; 51(5):604-12. PubMed ID: 26667347
[TBL] [Abstract][Full Text] [Related]
9. Periodontal treatment with topical antibiotics improves glycemic control in association with elevated serum adiponectin in patients with type 2 diabetes mellitus.
Bharti P; Katagiri S; Nitta H; Nagasawa T; Kobayashi H; Takeuchi Y; Izumiyama H; Uchimura I; Inoue S; Izumi Y
Obes Res Clin Pract; 2013; 7(2):e129-e138. PubMed ID: 24331774
[TBL] [Abstract][Full Text] [Related]
10. [Levels of interlukin-6 and tumor necrosis factor-α in saliva of patients with type 2 diabetes mellitus and oral lichen planus].
Liu Y; Jin JQ; Yuan ZF; Liu XS; Cao J; Guo XH; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):596-9. PubMed ID: 21844975
[TBL] [Abstract][Full Text] [Related]
11. Effect of non-surgical periodontal treatment on three salivary adipokines in diabetic patients with periodontitis.
Ziaei N; Golmohammadi S; Ataee M; Ardalani F; Mesgari Abbasi M
J Dent Res Dent Clin Dent Prospects; 2020; 14(3):199-205. PubMed ID: 33408827
[No Abstract] [Full Text] [Related]
12. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
13. Saliva and serum levels of B-cell activating factors and tumor necrosis factor-α in patients with periodontitis.
Gümüş P; Nizam N; Lappin DF; Buduneli N
J Periodontol; 2014 Feb; 85(2):270-80. PubMed ID: 23701482
[TBL] [Abstract][Full Text] [Related]
14. Local and serum levels of adipokines in patients with obesity after periodontal therapy: one-year follow-up.
Gonçalves TE; Zimmermann GS; Figueiredo LC; Souza Mde C; da Cruz DF; Bastos MF; da Silva HD; Duarte PM
J Clin Periodontol; 2015 May; 42(5):431-9. PubMed ID: 25858047
[TBL] [Abstract][Full Text] [Related]
15. [Association between periodontitis and diabetes mellitus].
Meng HX
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 39(1):18-20. PubMed ID: 17304319
[TBL] [Abstract][Full Text] [Related]
16. The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial.
Bazyar H; Gholinezhad H; Moradi L; Salehi P; Abadi F; Ravanbakhsh M; Zare Javid A
Inflammopharmacology; 2019 Feb; 27(1):67-76. PubMed ID: 30328031
[TBL] [Abstract][Full Text] [Related]
17. Periodontal disease progression and glycaemic control among Gullah African Americans with type-2 diabetes.
Bandyopadhyay D; Marlow NM; Fernandes JK; Leite RS
J Clin Periodontol; 2010 Jun; 37(6):501-9. PubMed ID: 20507373
[TBL] [Abstract][Full Text] [Related]
18. Impact of glycemic control on oral health status in type 2 diabetes individuals and its association with salivary and plasma levels of chromogranin A.
Kogawa EM; Grisi DC; Falcão DP; Amorim IA; Rezende TM; da Silva IC; Silva ON; Franco OL; de Amorim RF
Arch Oral Biol; 2016 Feb; 62():10-9. PubMed ID: 26605682
[TBL] [Abstract][Full Text] [Related]
19. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis.
Erdemir EO; Duran I; Haliloglu S
J Clin Periodontol; 2004 Feb; 31(2):99-104. PubMed ID: 15016034
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between adipocytokines levels and metabolic syndrome in type 2 diabetes mellitus].
Yan T; Li L; Wang H; Wang J; Cai D
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):275-8. PubMed ID: 24589612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
